Sandoz Rizatriptan Odt (2016-10-12)

Recall Summary Sandoz Rizatriptan ODT tablets have been recalled across Canada due to a product safety issue. Rizatriptan is a medication used to treat migraine headaches. This Class I recall affects all patients in Canada who have this product.

Reason

Product safety

Classification

Class I

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2016-10-24

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/c663829a-e7aa-4b5b-a0f8-803adf56dedf